
WASHINGTON, Dec. 7 (UPI) -- Hundreds of thousands of Americans may have benefited from drug-eluting stents but new research may throw them a costly curve.
The tiny tubes of metal mesh are used to prop open clogged coronary arteries so the heart can receive enough blood.
New studies indicate patients will have to continue their anti-clotting medications indefinitely, the Washington Post said. Otherwise, they could more than double their risk of a heart attack or death.
Since a year's supply of the clot-busting drug Plavix costs roughly $1,400, the findings could mean a long-term economic burden.
Mounting concern over the safety of drug-eluting stents is the hot topic at a two-day meeting convened by the Federal Drug Administration in Washington.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
NEW YORK, May 31 (UPI) --
Actor Michael McKean, who was hit by a car last week while walking in New York, says he has been discharged from St. Luke's Hospital.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption